Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-08 Purchase |
2022-12-12 8:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
55,250 | $2.096 | $115,804 | 144,024 (Direct) |
View |
| 2022-06-30 Sale |
2022-07-05 4:30 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
29,767 | $18.8 | $559,577 | 102,529 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-05 5:34 pm |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
10,000 | $30.04 | $300,395 | 207,795 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 5:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
19,800 | $29 | $574,200 | 77,511 (Direct) |
View |
| 2021-09-22 Sale |
2021-09-24 5:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
6,600 | $29 | $191,400 | 107,311 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-16 5:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
3,300 | $31.54 | $104,088 | 4,700 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-02 5:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
3,000 | $33.34 | $100,020 | 6,950 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 5:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
3,000 | $38.22 | $114,647 | 9,950 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 4:08 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
3,000 | $35.43 | $106,281 | 12,950 (Direct) |
View |
| 2021-03-09 Sale |
2021-03-11 5:51 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $35.48 | $354,845 | 187,985 (Direct) |
View |
| 2021-03-09 Sale |
2021-03-11 5:50 pm |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
5,000 | $35.71 | $178,551 | 217,795 (Direct) |
View |
| 2021-03-08 Sale |
2021-03-10 6:18 pm |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
10,000 | $35.45 | $354,507 | 72,578 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
3,000 | $33.87 | $101,618 | 15,950 (Direct) |
View |
| 2021-02-24 Sale |
2021-02-26 4:50 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $34.24 | $342,392 | 197,985 (Direct) |
View |
| 2021-02-24 Sale |
2021-02-26 4:49 pm |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
5,000 | $34.19 | $170,933 | 222,795 (Direct) |
View |
| 2021-02-24 Sale |
2021-02-26 4:48 pm |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
3,000 | $34.18 | $102,529 | 82,478 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-16 Other |
2022-12-20 7:30 pm |
N/A 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and Compliance Officer |
200,000 | $0 | 0 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:34 pm |
2022-12-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
323,517 | $0 | 323,517 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:34 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
194,917 | $0 | 194,917 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:33 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
57,042 | $0 | 57,042 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:32 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
57,042 | $0 | 57,042 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:32 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
57,042 | $0 | 57,042 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:31 pm |
2022-12-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO |
197,123 | $0 | 197,123 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:30 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
57,042 | $0 | 57,042 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-05 4:30 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
29,767 | $16 | 102,529 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-05 4:30 pm |
2012-07-10 2022-07-10 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
29,767 | $0 | 102,529 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:45 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
951,821 | $0 | 1,443,994 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:43 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
182,470 | $0 | 300,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:42 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
495,211 | $0 | 722,729 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:41 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
91,235 | $0 | 150,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:41 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
91,235 | $0 | 150,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:39 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and Compliance Officer |
495,404 | $0 | 722,236 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:38 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
91,235 | $0 | 150,000 (Direct) |
View |
| 2022-04-04 Exercise |
2022-04-05 5:34 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
10,000 | $3.24 | 207,795 (Direct) |
View |
| 2022-04-04 Exercise |
2022-04-05 5:34 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
10,000 | $0 | 207,795 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 5:00 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
19,800 | $3.24 | 77,511 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 5:00 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
19,800 | $0 | 77,511 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:01 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
20,000 | $3.24 | 217,795 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:01 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
20,000 | $0 | 217,795 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:31 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
492,173 | $0 | 492,173 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:31 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
58,765 | $0 | 58,765 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:31 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
58,765 | $0 | 58,765 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:30 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
227,518 | $0 | 227,518 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:30 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
117,530 | $0 | 117,530 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:30 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CAO and Compliance Officer |
226,832 | $0 | 226,832 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:30 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
58,765 | $0 | 58,765 (Direct) |
View |
| 2021-09-22 Exercise |
2021-09-24 5:00 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
10,000 | $4.6 | 107,311 (Direct) |
View |
| 2021-09-22 Exercise |
2021-09-24 5:00 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
1,900 | $0 | 107,311 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:00 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
10,000 | $4.6 | 117,200 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:00 pm |
2018-12-20 2028-12-20 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
10,000 | $0 | 117,200 (Direct) |
View |
| 2021-03-09 Exercise |
2021-03-11 5:51 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $3.24 | 187,985 (Direct) |
View |
| 2021-03-09 Exercise |
2021-03-11 5:51 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $0 | 187,985 (Direct) |
View |
| 2021-03-09 Exercise |
2021-03-11 5:50 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
5,000 | $3.24 | 217,795 (Direct) |
View |
| 2021-03-09 Exercise |
2021-03-11 5:50 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
5,000 | $0 | 217,795 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-10 6:18 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
10,000 | $3.24 | 72,578 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-10 6:18 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
10,000 | $0 | 72,578 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:50 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $3.24 | 197,985 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:50 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $0 | 197,985 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:49 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
5,000 | $3.24 | 222,795 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-26 4:49 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
5,000 | $0 | 222,795 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:48 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
3,000 | $3.24 | 82,478 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:48 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
3,000 | $0 | 82,478 (Direct) |
View |